Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments.

@article{Sato1985TranscatheterAE,
  title={Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments.},
  author={Yuhki Sato and Kansuke Fujiwara and Itsuro Ogata and Yasuyuki Ohta and Shigeki Hayashi and Yoshihiko Oka and Shigeru Furui and Hiroshi Oka},
  journal={Cancer},
  year={1985},
  volume={55 12},
  pages={2822-5}
}
Transcatheter arterial embolization (TAE) for unresectable hepatocellular carcinoma (HCC) was performed in cirrhotic patients with nonoccluded main portal trunk and total bilirubin levels less than 5 mg/dl. In 48 patients with tumor response to TAE, its benefit was evaluated by comparing their survival with that in 28 patients after conservative treatments, matched by clinical data. In TAE-treated patients, tumor findings on computerized tomography and angiogram were significantly different… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Primary Liver Cancer in Japan

Springer Japan • 1992
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…